PFE

Quick Look at Pfizer (PFE)

Pfizer moved 0.1% this afternoon session, trading between a high of $31.075 and a low of $30.51 per share. Yesterday the stock finished at $30.56 per share, compared to an average analyst target price of $38.67.

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. The large-cap biotechnology: pharmaceutical preparations company is based in the United States, and over the last twelve months it has returned a dividend yield of 5.3%. Pfizer has trailing twelve months earnings per share (EPS) of 3.76, which at today's prices amounts to a price to earnings (P/E) ratio of 8.1.

Based on its expected future earnings growth, the company has a price to earnings growth (PEG) ratio of -2.29. Usually a PEG ratio between 0 and 1 indicates a potentially undervalued company.

Overview of the Company's Gross Margins:

Date Reported Revenue ($ k) Cost of Revenue ($ k) Gross Margins (%) YoY Growth (%)
2023 105,685,000 23,835,000 77 -97.85
2022 -987,000 34,344,000 3579 5672.58
2021 81,288,000 30,821,000 62 -22.5
2020 41,651,000 8,484,000 80 0.0
2019 40,905,000 8,054,000 80 2.56
2018 40,825,000 8,987,000 78

At 659.3%, Pfizer's average gross margins are wider than the 60.94% average of its industry peer group, which suggests that the firm might have a competitive advantage.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS